ExPRES SEPSIS
Start date:January 2014 End date:
July 2015 Co-ordinated by:
University of Edinburgh & NHS Lothian
Early Prediction of Severe Sepsis
Aim
To derive a biomarker to allow the identification of patients with confirmed sepsis, and risk stratify patients at risk of developing severe sepsis
Trial Design
A Prospective, multi-centre cohort observational study
Chief Investigator
Professor Tim Walsh, Critical Care Research Group
Local PI
Professor Tim Walsh
Research Team
- EMERGE Research team
- Critical Care Research Group
- Rossi Lab, MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh
Eligibility criteria (summary)
Patients who present to the Emergency Department with suspected sepsis
Further information
http://www.ccm.mvm.ed.ac.uk/
http://www.cir.ed.ac.uk/
Research Team
Dr Deepankar Datta
Specialist Trainee Emergency Medicine
Julia Grahamslaw
Lead Research Nurse
Related news
More EMERGE Trials
Assisting in identifying patients with Humeral shaft fractures in the ED by screening.
Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.
HU-FIX Trial
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.
PRECISE-CTCA Trial
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.